By Nanogap
New therapeutic routes and early diagnostics Building on NANOGAP’s Metal Molecule technology, completely new paths to treat incurable cancer are being developed through our spin-out Arjuna Therapeutics. Arjuna’s Therapeutic Molecular Clusters (TMC’s) are a new class of medicine that acts as a catalyst within the cell structure targeting a known Achilles heel for multiple cancer indications. NANOGAP is also working on a fast and early diagnostic kit for pneumonia which is being developed with a world-class consortium within the Technology Incubator. With our unique Metal Molecule technology we are helping to solve unmet needs in therapeutic and diagnostic fields.
